QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, May 15, 2003, 23(10):4034-4043

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (30) Citing Articles via Google Scholar Google Scholar Articles by Le, D. M. Articles by Yong, V. W. Search for Related Content PubMed PubMed Citation Articles by Le, D. M. Articles by Yong, V. W.

 Previous Article  |  Next Article 

Exploitation of Astrocytes by Glioma Cells to Facilitate Invasiveness: A Mechanism Involving Matrix Metalloproteinase-2 and the Urokinase-Type Plasminogen Activator–Plasmin Cascade

Duc M. Le,¹ Arnaud Besson,¹ Darrin K. Fogg,² Kyu-Sil Choi,² David M. Waisman,² Cynthia G. Goodyer,⁵ Barry Rewcastle,³ and V. Wee Yong^1,4

Departments of ¹Oncology, ²Medical Science, ³Pathology, and ⁴Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada, and ⁵McGill University, Montreal Children's Hospital Research Institute, Montreal, Quebec, Canada,

The presence of reactive astrocytes around glioma cells in the CNS suggests the possibility that these two cell types could be interacting. We addressed whether glioma cells use the astrocyte environment to modulate matrix metalloproteinase-2 (MMP-2), a proteolytic enzyme implicated in the invasiveness of glioma cells. We found that astrocytes in culture produce significant amounts of the pro-form of MMP-2 but undetectable levels of active MMP-2. However, after coculture with the U251N glioma line, astrocyte pro-MMP-2 was converted to the active form. The mechanism of pro-MMP-2 activation in glioma–astrocyte coculture was investigated and was found to involve the urokinase-type plasminogen activator (uPA)–plasmin cascade whereby uPA bound to uPA receptor (uPAR), leading to the conversion of plasminogen to plasmin. The latter cleaved pro-MMP-2 to generate its active form. Furthermore, key components (i.e., uPAR, uPA, and pro-MMP-2) were contributed principally by astrocytes, whereas the U251N glioma cells provided plasminogen. In correspondence with this biochemical cascade, the transmigration of U251N cells through Boyden invasion chambers coated with an extracellular matrix barrier was increased significantly in the presence of astrocytes, and this was inhibited by agents that disrupted the uPA–plasmin cascade. Finally, using resected human glioblastoma specimens, we found that tumor cells, but not astrocytes, expressed plasminogen in situ. We conclude that glioma cells exploit their astrocyte environment to activate MMP-2 and that this leads to the increased invasiveness of glioma cells.

Key words: astrocytes; brain tumors; glioma; metalloproteinases; metastasis; plasmin

---

Received Apr. 15, 2002; revised Feb. 12, 2003; accepted Feb. 19, 2003.

This article has been cited by other articles:

				J.-Y. C. Hsu, L. Y. W. Bourguignon, C. M. Adams, K. Peyrollier, H. Zhang, T. Fandel, C. L. Cun, Z. Werb, and L. J. Noble-Haeusslein Matrix Metalloproteinase-9 Facilitates Glial Scar Formation in the Injured Spinal Cord J. Neurosci., December 10, 2008; 28(50): 13467 - 13477. [Abstract] [Full Text] [PDF]

				D. B. Hoelzinger, T. Demuth, and M. E. Berens Autocrine Factors That Sustain Glioma Invasion and Paracrine Biology in the Brain Microenvironment J Natl Cancer Inst, November 7, 2007; 99(21): 1583 - 1593. [Abstract] [Full Text] [PDF]

				Y. He, X.-d. Liu, Z.-y. Chen, J. Zhu, Y. Xiong, K. Li, J.-h. Dong, and X. Li Interaction between Cancer Cells and Stromal Fibroblasts Is Required for Activation of the uPAR-uPA-MMP-2 Cascade in Pancreatic Cancer Metastasis Clin. Cancer Res., June 1, 2007; 13(11): 3115 - 3124. [Abstract] [Full Text] [PDF]

				S. Sarkar, R. K. Nuttall, S. Liu, D. R. Edwards, and V. W. Yong Tenascin-C Stimulates Glioma Cell Invasion through Matrix Metalloproteinase-12 Cancer Res., December 15, 2006; 66(24): 11771 - 11780. [Abstract] [Full Text] [PDF]

				H. Gardsvoll, B. Gilquin, M. H. Le Du, A. Menez, T. J. D. Jorgensen, and M. Ploug Characterization of the Functional Epitope on the Urokinase Receptor: COMPLETE ALANINE SCANNING MUTAGENESIS SUPPLEMENTED BY CHEMICAL CROSS-LINKING J. Biol. Chem., July 14, 2006; 281(28): 19260 - 19272. [Abstract] [Full Text] [PDF]

				J. Zhang, S. Sarkar, and V.W. Yong The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase Carcinogenesis, December 1, 2005; 26(12): 2069 - 2077. [Abstract] [Full Text] [PDF]

				Y. Zhou, J. Zhang, Q. Liu, R. Bell, D. A. Muruve, P. Forsyth, M. Arcellana-Panlilio, S. Robbins, and V.W. Yong The chemokine GRO-{alpha} (CXCL1) confers increased tumorigenicity to glioma cells Carcinogenesis, December 1, 2005; 26(12): 2058 - 2068. [Abstract] [Full Text] [PDF]

				Z. A. HAROON, K. AMIN, P. LICHTLEN, B. SATO, N. T. HUYNH, Z. WANG, W. SCHAFFNER, and B. J. MURPHY Loss of metal transcription factor-1 suppresses tumor growth through enhanced matrix deposition FASEB J, August 1, 2004; 18(11): 1176 - 1184. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help